Zacks.com on MSN4h
Amgen Shrugs Off Bone Density Concerns Related to Obesity Candidate
Key Takeaways Amgen refutes in a press release that its trial obesity drug, MariTide, may cause bone loss density. Amgen's ...
Could Ozempic Help Treat Substance Use Disorder? This Expert Is Hopeful
More than 48 million Americans 12 years or older had a substance use disorder in 2022, yet only 24 percent received treatment ...
Comparing Oral vs. Injectable Semaglutide: Is One More Effective Than the Other?
It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...
Why maker of ‘magic’ weight-loss drug semaglutide wants copies banned
US Food and Drug Administration (FDA) regulations allow human drug compounding — in which licensed pharmacists or physicians ...